Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04447976
Other study ID # HSC-MS-20-0408
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 2, 2020
Est. completion date July 2022

Study information

Verified date January 2021
Source The University of Texas Health Science Center, Houston
Contact Prithvi Patil, MS
Phone 713-500-6456
Email prithvi.b.patil@uth.tmc.edu
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose: To evaluate overall performance of disposable TIP duodenoscopes and get insight from end-users regarding its performance during various steps of ERCP procedure as well as ease and feasibility of pre-procedure duodenoscope set up and post procedure manual cleaning as well as reprocessing. Research design: This is a prospective observational multi-center study. Procedure used: During ERCP Risks and potential benefits: There are no risks associated with this study as it is a retrospective chart review. Potential benefits include the knowledge gained from this study which may be of help to patients in the future. Importance of knowledge that may reasonably be expected to result: The quality of health care which will be crucial to identify patterns of competence and identify areas of continued improvement. More specifically in the quality metrics sector we will be able to see what is already in place and steps we will undertake that will be beneficial for physicians.


Description:

This is a prospective study to evaluate performance of disposable TIP duodenoscopes. Scope is designed to facilitate effective reprocessing of duodenoscope and thus prevent future outbreaks related to contaminated duodenoscope despite standard reprocessing. This is a multi-center study being performed at the University of Texas Health Science Center, Wake Forest Baptist Health and Institute of Gastroenterology in Ecuador. The study will enroll a total of 100 patients who undergo ERCP. The study is purely observational as it will collect clinical success and information of the TIP duodenoscope.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 2022
Est. primary completion date October 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: - Any adult patients undergoing ERCP. - Patient has a clinical indication for ERCP. Exclusion Criteria: - Any patients less than 18 years old undergoing ERCP as medical necessary procedure. - Patients who refuse to consent for ERCP procedure.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States Memorial Hermann Hospital Houston Texas

Sponsors (3)

Lead Sponsor Collaborator
The University of Texas Health Science Center, Houston Instituto Ecuatoriano de Enfermedades Digestivas, Wake Forest University Health Sciences

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disposable TIP duodenoscope survey evaluation performance To evaluate overall performance of disposable TIP duodenoscope through a survey regarding its performance during various steps of ERCP procedure. During procedure
Primary To get insight from end-users such as physicians, fellows in training and nurse technicians regarding the disposable TIP duodenoscope performance during various steps of ERCP procedure through a questionnaire provided. To evaluate overall performance of disposable TIP duodenoscopes through a survey and get insight from end-users such as physicians, fellows in training and nurse technicians regarding its performance during various steps of ERCP procedure. during procedure
See also
  Status Clinical Trial Phase
Completed NCT02041390 - Effect of Short Message Service Intervention on Stent Removal/Exchange Adherence in Patients With Benign Pancreaticobiliary Diseases N/A
Completed NCT04619511 - Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
Terminated NCT00419549 - Efficacy Study of Glyceryl-Trinitrate Patch and Parecoxib (Valdecoxib) for the Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 2/Phase 3
Recruiting NCT04255095 - Early Intervention of High Tension in the Pancreatic Duct on the Outcome of Severe Biliary Pancreatitis N/A
Completed NCT05220774 - Conscious Sedation Versus Anesthesia for ERCP
Completed NCT03698266 - Is Needle Knife Fistulotomy An Effective First Step Strategy For All ERCPs? N/A
Recruiting NCT03350555 - Clinical Trials to Validate the Use of Additioned Endoscopy in Endoscopic Retrograde Cholangiopancreatography N/A
Completed NCT04671095 - Single Use ERCP Performance -SURE Study
Recruiting NCT05603702 - STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis Phase 1
Completed NCT03185390 - Periampullary Lesions Via ERCP in Assuit University Hospital N/A
Enrolling by invitation NCT03416205 - A Prospective Study of Treating Duodenal Papillary Sphincter in Different Ways During ERCP N/A
Recruiting NCT05211206 - IV Fluids and Post-ERCP Pancreatitis
Not yet recruiting NCT04658212 - A Multicenter Randomized Controlled Study of 3D Laparoscopy Versus Endoscopy in the Treatment of Choledocholithiasis N/A
Recruiting NCT04661332 - Registry of Endoscopic Retrograde Cholangiopancreatographies Performed in Humans
Terminated NCT02046590 - RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP N/A
Recruiting NCT05219123 - Guidewire Management in ERCP
Completed NCT00731198 - Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP) Phase 3
Completed NCT04167592 - Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP N/A
Completed NCT01873079 - PPI for Prevention of Post-sphincterotomy Bleeding Phase 3
Not yet recruiting NCT05225909 - aScope Single Use ERCP Study- ASSURE Study